TRAVAGLINI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 1.623
EU - Europa 883
AS - Asia 825
SA - Sud America 74
Continente sconosciuto - Info sul continente non disponibili 26
AF - Africa 16
OC - Oceania 1
Totale 3.448
Nazione #
US - Stati Uniti d'America 1.564
CN - Cina 276
SG - Singapore 271
IE - Irlanda 119
UA - Ucraina 109
GB - Regno Unito 102
IT - Italia 102
SE - Svezia 99
DE - Germania 93
TR - Turchia 92
RU - Federazione Russa 91
FR - Francia 73
VN - Vietnam 68
BR - Brasile 67
IN - India 45
FI - Finlandia 41
CA - Canada 29
NL - Olanda 10
JP - Giappone 9
BD - Bangladesh 8
CZ - Repubblica Ceca 8
HK - Hong Kong 8
MX - Messico 8
PL - Polonia 8
CH - Svizzera 7
ES - Italia 6
SA - Arabia Saudita 6
BE - Belgio 5
CR - Costa Rica 5
IL - Israele 5
ZA - Sudafrica 5
IQ - Iraq 4
IR - Iran 4
JO - Giordania 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
EU - Europa 3
GR - Grecia 3
HN - Honduras 3
KE - Kenya 3
PH - Filippine 3
RS - Serbia 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
CL - Cile 2
ID - Indonesia 2
KR - Corea 2
MA - Marocco 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
TN - Tunisia 2
AU - Australia 1
AW - Aruba 1
BH - Bahrain 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
HT - Haiti 1
JM - Giamaica 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
TH - Thailandia 1
TL - Timor Orientale 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
VI - Stati Uniti Isole Vergini 1
Totale 3.425
Città #
Singapore 198
Chandler 165
Jacksonville 148
San Jose 138
Dublin 119
Ashburn 114
Dallas 92
Beijing 82
Southend 80
The Dalles 60
Council Bluffs 57
Princeton 54
Nanjing 50
New York 45
Izmir 39
Los Angeles 31
Munich 31
Santa Clara 29
Dearborn 26
Buffalo 25
Ho Chi Minh City 25
Cambridge 24
Ann Arbor 21
Hanoi 19
Moscow 19
Wilmington 19
Nanchang 18
Altamura 17
Tongling 17
Chieti 14
Montreal 13
Grevenbroich 12
Washington 12
Frankfurt am Main 11
Turku 11
Denver 9
Redondo Beach 9
Shenyang 9
São Paulo 9
Hong Kong 8
Norwalk 8
Phoenix 8
Tokyo 8
Torino 8
Brooklyn 7
Carrboro 7
Fermo 7
Guangzhou 7
Kunming 7
North Bergen 7
Toronto 7
Warsaw 7
Amsterdam 6
Atlanta 6
Brno 6
Chicago 6
Fribourg 6
Hangzhou 6
Monmouth Junction 6
Orem 6
Stockholm 6
Tianjin 6
Boardman 5
Camerino 5
Changchun 5
Changsha 5
Hebei 5
Helsinki 5
Houston 5
Mexico City 5
Amman 4
Ankara 4
Brussels 4
Jiaxing 4
Jinan 4
Lanzhou 4
Montesilvano Marina 4
Poplar 4
San Francisco 4
Annapolis 3
Ardabil 3
Augusta 3
Baghdad 3
Belgrade 3
Chennai 3
Columbus 3
Johannesburg 3
London 3
Minneapolis 3
Mumbai 3
San José 3
San Mateo 3
San Vito Chietino 3
Biên Hòa 2
Boston 2
Brasília 2
Campobasso 2
Caxias do Sul 2
Concord 2
Curitiba 2
Totale 2.159
Nome #
Cleavage of cystatin C is not associated with multiple sclerosis 183
Increasing age at disability milestones among MS patients in the MSBase Registry 161
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 160
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 159
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 152
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 152
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 150
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 150
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 147
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 146
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 145
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 139
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 137
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 136
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 132
JCV-Ab serostatus in MS patients treated with Natalizumab 131
Natalizumab-associated PML-IRIS: the Chieti experience. 125
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 124
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 117
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 115
New daily persistent headache after SARS-CoV-2 infection: a report of two cases 107
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 105
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 102
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 99
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis 90
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 84
Totale 3.448
Categoria #
all - tutte 13.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202286 0 0 0 0 5 2 11 8 10 4 14 32
2022/2023418 29 66 27 35 48 78 21 30 63 5 8 8
2023/2024235 13 9 17 3 24 113 24 0 1 6 3 22
2024/2025462 30 34 46 7 8 22 16 18 30 30 110 111
2025/20261.013 88 24 121 151 121 45 169 39 115 78 50 12
2026/2027281 17 43 67 106 48 0 0 0 0 0 0 0
Totale 3.448